Correlation between magnetic resonance images of peritumor margin enhancement and prognosis in hepatocellular carcinoma after drug-eluting bead transcatheter arterial chemoembolization

PurposeThe aim of this study is to investigate the morphological characteristics and clinical significance of magnetic resonance (MR) images of peritumor margin enhancement in hepatocellular carcinoma (HCC) after drug-eluting bead transcatheter arterial chemoembolization (DEB-TACE).MethodsFrom Janua...

Full description

Bibliographic Details
Main Authors: Donglin Kuang, Nan Zhang, Mengfan Zhang, Hao Li, Xinwei Han, Jianzhuang Ren, Xuhua Duan
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-04-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.957710/full
_version_ 1797852910119288832
author Donglin Kuang
Nan Zhang
Mengfan Zhang
Hao Li
Xinwei Han
Jianzhuang Ren
Xuhua Duan
author_facet Donglin Kuang
Nan Zhang
Mengfan Zhang
Hao Li
Xinwei Han
Jianzhuang Ren
Xuhua Duan
author_sort Donglin Kuang
collection DOAJ
description PurposeThe aim of this study is to investigate the morphological characteristics and clinical significance of magnetic resonance (MR) images of peritumor margin enhancement in hepatocellular carcinoma (HCC) after drug-eluting bead transcatheter arterial chemoembolization (DEB-TACE).MethodsFrom January 2017 to December 2020, a total of 162 patients who received a diagnosis of HCC were included in our study. We began the follow-up with magnetic resonance imaging (MRI) for complete response assessment, and peritumor margin enhancements were classified as sharp and rough types according to morphology. During the follow-up, data such as progression or remission of the two enhancement modalities, morphological changes in terms of margin enhancements observed in MR images, and alpha-fetoprotein (AFP) levels were recorded.ResultsIn the follow-up period of 36 months, 70 and 92 patients with sharp- and rough-type peritumor margins, respectively, were observed. At the end of the follow-up, patients with sharp-type margins had lower AFP levels and longer progression-free survival than those with rough-type margins (P < 0.05). Furthermore, the sharp-type margin was thinner than the rough-type margin (all P < 0.05). Moreover, the sharp-type group had a high incidence of tumors with a diameter of < 5 cm, whereas the rough-type group had a high incidence of tumors with a diameter of ≥ 5 cm. Continuous enhancements of peritumor margins in MRI were greater in the sharp-type group than in the rough-type group. Most of the patients with a sharp-type margin achieved disease remission (94.3%, P < 0.05), whereas most of those with a rough-type margin experienced disease progression (84.8%, P < 0.05).ConclusionsPatients with HCC with a sharp-type margin enhancement on MRI after DEB-TACE mostly demonstrated benign lesions with a good prognosis, whereas those with a rough-type margin mostly demonstrated malignant growth.
first_indexed 2024-04-09T19:41:58Z
format Article
id doaj.art-5090ef7d0e5948b0badb338417bc3694
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-04-09T19:41:58Z
publishDate 2023-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-5090ef7d0e5948b0badb338417bc36942023-04-04T05:21:07ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2023-04-011310.3389/fonc.2023.957710957710Correlation between magnetic resonance images of peritumor margin enhancement and prognosis in hepatocellular carcinoma after drug-eluting bead transcatheter arterial chemoembolizationDonglin KuangNan ZhangMengfan ZhangHao LiXinwei HanJianzhuang RenXuhua DuanPurposeThe aim of this study is to investigate the morphological characteristics and clinical significance of magnetic resonance (MR) images of peritumor margin enhancement in hepatocellular carcinoma (HCC) after drug-eluting bead transcatheter arterial chemoembolization (DEB-TACE).MethodsFrom January 2017 to December 2020, a total of 162 patients who received a diagnosis of HCC were included in our study. We began the follow-up with magnetic resonance imaging (MRI) for complete response assessment, and peritumor margin enhancements were classified as sharp and rough types according to morphology. During the follow-up, data such as progression or remission of the two enhancement modalities, morphological changes in terms of margin enhancements observed in MR images, and alpha-fetoprotein (AFP) levels were recorded.ResultsIn the follow-up period of 36 months, 70 and 92 patients with sharp- and rough-type peritumor margins, respectively, were observed. At the end of the follow-up, patients with sharp-type margins had lower AFP levels and longer progression-free survival than those with rough-type margins (P < 0.05). Furthermore, the sharp-type margin was thinner than the rough-type margin (all P < 0.05). Moreover, the sharp-type group had a high incidence of tumors with a diameter of < 5 cm, whereas the rough-type group had a high incidence of tumors with a diameter of ≥ 5 cm. Continuous enhancements of peritumor margins in MRI were greater in the sharp-type group than in the rough-type group. Most of the patients with a sharp-type margin achieved disease remission (94.3%, P < 0.05), whereas most of those with a rough-type margin experienced disease progression (84.8%, P < 0.05).ConclusionsPatients with HCC with a sharp-type margin enhancement on MRI after DEB-TACE mostly demonstrated benign lesions with a good prognosis, whereas those with a rough-type margin mostly demonstrated malignant growth.https://www.frontiersin.org/articles/10.3389/fonc.2023.957710/fullhepatocellular carcinomadrug-eluting bead transcatheter arterial chemoembolizationmagnetic resonance imagingmargin enhancementmorphology
spellingShingle Donglin Kuang
Nan Zhang
Mengfan Zhang
Hao Li
Xinwei Han
Jianzhuang Ren
Xuhua Duan
Correlation between magnetic resonance images of peritumor margin enhancement and prognosis in hepatocellular carcinoma after drug-eluting bead transcatheter arterial chemoembolization
Frontiers in Oncology
hepatocellular carcinoma
drug-eluting bead transcatheter arterial chemoembolization
magnetic resonance imaging
margin enhancement
morphology
title Correlation between magnetic resonance images of peritumor margin enhancement and prognosis in hepatocellular carcinoma after drug-eluting bead transcatheter arterial chemoembolization
title_full Correlation between magnetic resonance images of peritumor margin enhancement and prognosis in hepatocellular carcinoma after drug-eluting bead transcatheter arterial chemoembolization
title_fullStr Correlation between magnetic resonance images of peritumor margin enhancement and prognosis in hepatocellular carcinoma after drug-eluting bead transcatheter arterial chemoembolization
title_full_unstemmed Correlation between magnetic resonance images of peritumor margin enhancement and prognosis in hepatocellular carcinoma after drug-eluting bead transcatheter arterial chemoembolization
title_short Correlation between magnetic resonance images of peritumor margin enhancement and prognosis in hepatocellular carcinoma after drug-eluting bead transcatheter arterial chemoembolization
title_sort correlation between magnetic resonance images of peritumor margin enhancement and prognosis in hepatocellular carcinoma after drug eluting bead transcatheter arterial chemoembolization
topic hepatocellular carcinoma
drug-eluting bead transcatheter arterial chemoembolization
magnetic resonance imaging
margin enhancement
morphology
url https://www.frontiersin.org/articles/10.3389/fonc.2023.957710/full
work_keys_str_mv AT donglinkuang correlationbetweenmagneticresonanceimagesofperitumormarginenhancementandprognosisinhepatocellularcarcinomaafterdrugelutingbeadtranscatheterarterialchemoembolization
AT nanzhang correlationbetweenmagneticresonanceimagesofperitumormarginenhancementandprognosisinhepatocellularcarcinomaafterdrugelutingbeadtranscatheterarterialchemoembolization
AT mengfanzhang correlationbetweenmagneticresonanceimagesofperitumormarginenhancementandprognosisinhepatocellularcarcinomaafterdrugelutingbeadtranscatheterarterialchemoembolization
AT haoli correlationbetweenmagneticresonanceimagesofperitumormarginenhancementandprognosisinhepatocellularcarcinomaafterdrugelutingbeadtranscatheterarterialchemoembolization
AT xinweihan correlationbetweenmagneticresonanceimagesofperitumormarginenhancementandprognosisinhepatocellularcarcinomaafterdrugelutingbeadtranscatheterarterialchemoembolization
AT jianzhuangren correlationbetweenmagneticresonanceimagesofperitumormarginenhancementandprognosisinhepatocellularcarcinomaafterdrugelutingbeadtranscatheterarterialchemoembolization
AT xuhuaduan correlationbetweenmagneticresonanceimagesofperitumormarginenhancementandprognosisinhepatocellularcarcinomaafterdrugelutingbeadtranscatheterarterialchemoembolization